# Paclitaxel-eluting Balloon Angioplasty With Provisional Use of Nitinol Stent Versus Systematic Implantation of Paclitaxel-eluting Stent for the Treatment of Femoropopliteal de Novo Lesions

Study · id `cardio:ct-nct01969630` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01969630](<https://clinicaltrials.gov/study/NCT01969630>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01969630

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 250 participants.

## Technical summary

Registry record NCT01969630. Randomized; single masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2015-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 250 participants (planned count; ClinicalTrials.gov record NCT01969630, source copy `cardio:ctgov-nct01969630-2013-10-25`, retrieved 2026-10-31)
- Start date: 2013-10 (registry gives no type) (ClinicalTrials.gov record NCT01969630, source copy `cardio:ctgov-nct01969630-2013-10-25`, retrieved 2026-10-31)
- Primary completion: 2015-10 (anticipated) (ClinicalTrials.gov record NCT01969630, source copy `cardio:ctgov-nct01969630-2013-10-25`, retrieved 2026-10-31)
- Completion: Not reported
- Countries: Italy (ClinicalTrials.gov record NCT01969630, source copy `cardio:ctgov-nct01969630-2013-10-25`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01969630-2013-10-25`, retrieved 2026-10-31)

## The registry's words

- Brief title: Paclitaxel-eluting Balloon Angioplasty With Provisional Use of Nitinol Stent Versus Systematic Implantation of Paclitaxel-eluting Stent for the Treatment of Femoropopliteal de Novo Lesions
- Condition: Peripheral Artery Disease
- Intervention (Device): PEB
- Intervention (Device): PES
- Lead sponsor: Ospedale San Donato
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Ospedale San Donato (`cardio:org-ospedale-san-donato`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Drug-Eluting Balloon Versus Drug-Eluting Stent for Complex Femoropopliteal Arterial Lesions: The DRASTICO Study (`cardio:pubmed-31296293`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: e4139207635dff5ed11535c302cd6cd040de5afdf0644f0adc8c47b9aaff807a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
